Clinical trials in children
- PMID: 24325152
- PMCID: PMC4345947
- DOI: 10.1111/bcp.12305
Clinical trials in children
Abstract
Safety and efficacy data on many medicines used in children are surprisingly scarce. As a result children are sometimes given ineffective medicines or medicines with unknown harmful side effects. Better and more relevant clinical trials in children are needed to increase our knowledge of the effects of medicines and to prevent the delayed or non-use of beneficial therapies. Clinical trials provide reliable evidence of treatment effects by rigorous controlled testing of interventions on human subjects. Paediatric trials are more challenging to conduct than trials in adults because of the paucity of funding, uniqueness of children and particular ethical concerns. Although current regulations and initiatives are improving the scope, quantity and quality of trials in children, there are still deficiencies that need to be addressed to accelerate radically equitable access to evidence-based therapies in children.
Keywords: clinical trials; ethics; medicines in children; paediatric drug therapy.
© 2013 The British Pharmacological Society.
Figures
References
-
- Wilson JT. An update on the therapeutic orphan. Pediatrics. 1999;104(Suppl. 3):585–590. - PubMed
-
- Shirkey H. Therapeutic orphans. J Pediatr. 1968;72:119–120. - PubMed
-
- Shirkey H. Editorial comment: therapeutic orphans. J Pediatr. 1999;104:583–584. - PubMed
-
- Sammons H, Gray C, Hudson H, Cherrill J, Choonara I. Safety in paediatric clinical trials – a 7-year review. Acta Paediatr. 2008;97:474–477. - PubMed
-
- Klassen TP, Hartling L, Hamm M, van der Lee JH, Ursum J, Offringa M. StaR Child Health: an initiative for RCTs in children. Lancet. 2009;374:1310–1312. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
